Graves’ disease in a Down’s syndrome patient responds well to radioiodine rather than antithyroid drugs

2011 ◽  
Vol 24 (7-8) ◽  
Author(s):  
Nishikant Damle ◽  
Kalpajyoti Das ◽  
Chandrasekhar Bal
Keyword(s):  
Down's Syndrome ◽  
Down’S Syndrome ◽  
Antithyroid Drugs ◽  
Graves Disease ◽  
Syndrome Patient

Graves' Disease in a Down's Syndrome Patient

2010 ◽  
Vol 23 (11) ◽  
Author(s):  
Mohammad Hayat Bhat ◽  
Sameena Saba ◽  
Irfan Ahmed ◽  
M. M. A. Kamili ◽  
Shaukat A. Khan
Keyword(s):  
Down's Syndrome ◽  
Down’S Syndrome ◽  
Graves Disease ◽  
Syndrome Patient

scholarly journals Trisomy 18 and trisomy 21 mosaicism in a Down's syndrome patient.

1994 ◽  
Vol 31 (5) ◽  
pp. 418-419 ◽  
Author(s):  
I M Thomas ◽  
R Sayee ◽  
L Shavanthi ◽  
H Sridevi
Keyword(s):  
Trisomy 21 ◽  
Down's Syndrome ◽  
Down’S Syndrome ◽  
Trisomy 18 ◽  
Syndrome Patient

scholarly journals Graves Disease And Down Sindrome : Clinical Case

2015 ◽  
Vol 21 (3) ◽  
pp. 163-168 ◽  
Author(s):  
Olesea Scrinic ◽  
Seila Ibadula ◽  
E. Circo
Keyword(s):  
Down Syndrome ◽  
Side Effects ◽  
Clinical Case ◽  
Down's Syndrome ◽  
Down’S Syndrome ◽  
Graves Disease ◽  
Ocular Involvement ◽  
Endocrine Disorders ◽  
Clinical Evolution ◽  
Antithyroid Therapy

ABSTRACT Introduction: Pacients with Down’s syndrome present an increase revalence of autoimune endocrine disorders. We communicate the case of 14 years and 6 months old pacient known with Down syndrome admitted in Endocrinology department with suspicion of hyperthyroidism, the diagnosis being confirmed by hormonal dosage. The particularity of the case consists in: symptomatology onset during puberty, clinical evolution with mild symptoms, without ocular involvement, morphological and functional remission obtained relatively soon after the initiation of antithyroid therapy, lack of posttherapy side effects, favorabile evolution under the “block and replace” therapy

Sign in / Sign up

Export Citation Format

Share Document